Feng Tian is the founder of Ambrx. He leads the company in developing Engineered Precision Biologics using an expanded genetic code technology platform.
Feng Tian is the Co-founder, Chief Executive Officer, and Chairman of the Board of Ambrx Biopharma Inc., a clinical-stage biopharmaceutical company. He leads the company in developing Engineered Precision Biologics using an expanded genetic code technology platform.
Full founder directory · Investor directory · Company funding database · Fundraising library